In the News |
October 28, 2024
Synaffix, industry’s ADC partner of choice, spins out a startup pipeline

“The Dutch biotech Synaf­fix has long been one of the top part­ners for bio­phar­ma com­pa­nies work­ing in an­ti­body-drug con­ju­gates. Now the com­pa­ny is spin­ning out …”

Kyle LaHucik, Endpoints News